CRNX Crinetics Pharmaceuticals, Inc.

NEUTRAL Impact: 3/10 PRESS-RELEASE
Horizon days Filed Apr 8, 2026 Processed 2mo ago Wire GlobeNewswire
Press release: earnings
Latest settled — T+20d
CRNX ▲ +5.25% at T+20d
NEUTRAL call ✓ call won +5.25% · α vs SPY -2.32% · entry $39.63 → $41.71
Next anchor: T+60d in 18d
Last close $34.47 (close Jun 12) · -13.02% from $39.63 entry
Entry anchored
Apr 8, 03:59 PM ET
via Databento tick
T+1d
-0.48%
call -0.48% · α -0.42%
$39.44
settled 2mo ago
T+5d
-1.54%
call -1.54% · α -4.73%
$39.02
settled 2mo ago
T+20d
+5.25%
call +5.25% · α -2.32%
$41.71
settled 6w ago
T+60d
call — · α —
in 18d

Price Chart

Loading chart...

Executive Summary

Crinetics Pharmaceuticals announced a future earnings date for Q1 2026 but did not release actual financial results in this press release. The company reiterated its business update and pipeline progress without providing any new financial data for the reported period.

Actionable Insight

Traders should monitor the May 7 earnings call for actual financial performance and potential guidance updates; this release only sets expectations for disclosure timing.

Key Facts

  • Crinetics will report Q1 2026 financial results on May 7, 2026, after market close.
  • No financial results were released in this announcement — only a schedule for future reporting.
  • Management will host a conference call to discuss results and provide a business update.
  • The press release emphasizes pipeline progress, including PALSONIFY™ and late-stage candidate atumelnant.
  • No financial metrics (revenue, EPS, guidance) were disclosed for Q1 2026 or any prior period in this filing.

Financial Impact

No financial impact from this filing — no results released.

Risk Factors

  • Lack of financial disclosure limits near-term trading catalysts.
  • Recent insider selling ($651K over 30 days) may signal caution ahead of earnings.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3270499
7 reports for CRNX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CRNX — sortable, filterable
Type Now
Jun 14, 2026
today
Press Release
BULLISH ★ 6/10
awaiting T+20
Jun 14, 2026
today
Press Release
BULLISH ★ 6/10
awaiting T+20
May 7, 2026
5w ago
8-K
NEUTRAL ★ 5/10
$37.48 $32.92▼ −12.17%▼ −12.19%$34.47 (−8.03%)
Apr 10, 2026
9w ago
8-K
NEUTRAL ★ 3/10
$38.66 $36.55▼ −5.46%▼ −13.19%$34.47 (−10.84%)
Apr 8, 2026
9w ago
Press Release
NEUTRAL ★ 3/10
$39.63 $41.71▲ +5.25%▼ −2.32%$34.47 (−13.02%)
Mar 12, 2026
13w ago
Insider Cluster
BEARISH ★ 6/10
$36.51 $39.44▼ −8.03%▼ −6.05%$34.47 (+5.59%)
Feb 26, 2026
15w ago
8-K
MIXED ★ 7/10
$41.10 $33.67▼ −18.08%▼ −10.52%$34.47 (−16.13%)
Showing 7 of 7

US Market Status

Market Closed — Opens in 5h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access